Skip to main content
. 2024 May 23;15:1253072. doi: 10.3389/fimmu.2024.1253072

Figure 5.

Figure 5

Survival Analysis. (A) Survival analysis of all PDAC patients with and without peritoneal carcinomatosis (PDAC (PER+) + PDAC (PER-)). p=0.0482, n=27. (B) Survival analysis of only PDAC (PER-) patients without peritoneal carcinomatosis. p=0.1699, n=18. Blue: High expression of exo-ROR1, Black: Low expression of exo-ROR1. (C) Survival analysis according to ROR1 mRNA in tumor tissue. p=0.8414, n=25. Blue: High expression of ROR1 mRNA, Black: Low expression of ROR1 mRNA.